Decentriq and Nanoleq participate in large European initiatives

Decentriq’s state-of-the-art data collaboration platform is a core component of iCARE4CVD’s data architecture. iCARE4CVD is an international, public-private research consortium launched on October 25, 2023 is funded by the Innovative Health Initiative (IHI), a joint undertaking of the European Commission and the European life science industry. The consortium is one of the first to be funded by the new IHI framework (former IMI), funded by both industry and public partners, comprises 33 prominent global collaborators from various sectors and will run for 54 months, led by the University of Maastricht and Novo Nordisk.

Using a combination of artificial intelligence, biomarkers, and large datasets, the project seeks to personalize treatments and improve the outcomes of patients suffering from Cardiovascular diseases (CVDs). In the platform, participants contribute their data for research in data-clean rooms and secure environments protected by a combination of advanced privacy technologies, including Confidential Computing. Decentriq will perform three essential functions for the consortium’s research: facilitating data encryption, preserving the privacy of any results generated, and machine learning analysis.

Smart wearables for monitoring mothers and babies
Nanoleq, the startup at the forefront of smart textiles, driven by a mission to elevate well-being, is participating in the groundbreaking 3-year, €19.3 million Newlife KDT Project with 25 partners from 6 different European countries. Naloleg is involved in the use case “Fetal monitoring patch for high-risk pregnancies”, along with two consortium partners, Philips Electronics Netherland B.V. and Noldus Information Technology, a Netherlands-based solutions provider for behavioural research.

The project aims to develop cutting-edge smart wearables that enable early and non-invasive detection of pregnancy risk factors and newborn monitoring. Nanoleq experts contribute with comfortable e-textile technology to Newlife’s smart wearables for monitoring pregnant women and babies. Furthermore, Nanoleq provides an interactive bio-feedback wearable for expectant mothers with pregnancy-specific breathing training to help them better manage their body's response to stress, improve their sleep quality and empower them to enhance their well-being during pregnancy and beyond.

Philips will lead the NEWLIFE project chapter, and as a large key player and leader in diagnostic imaging, patient monitoring and health informatics, Philips Electronics will bring their expertise and knowledge in wearable ultra-sound patches, which is a multi-modality solution combining imaging and monitoring, helping clinicians personalize and define the care path that each high-risk pregnancy requires. On the other hand, the Noldus team will contribute their expertise to use cases on the post-natal monitoring solutions and data disclosure, specifically collecting and visualizing sensor data together with context-giving video and annotations for researchers looking for insights into the combination of the sensor data.

(Press release/RAN)